7 results
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
7 Nov 23
Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
in the extension trial.
Late-Breaking Poster Presented at ASN’s Kidney Week 2023 – The late-breaking poster presented at the American Society of Nephrology’s (ASN
8-K
MLYS
Mineralys Therapeutics Inc
2 Nov 23
Regulation FD Disclosure
10:06am
-Breaking Posters session at the American Society of Nephrology (ASN) Kidney Week 2023, which is being held in Philadelphia from November 2–5. A copy
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
2 Nov 23
Regulation FD Disclosure
10:06am
hypertension (rHTN). The data were presented during the Late-Breaking Posters session at the American Society of Nephrology (ASN) Kidney Week 2023, which
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
at miRagen, Vertex Pharmaceuticals Inc., and Novartis Institutes for BioMedical Research. Dr. Rodman was elected to the American Society for Clinical
DRS/A
tmczhwt 9e4i
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
fv0 g8098i
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next